A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).
Br J Dermatol
; 179(4): 836-843, 2018 10.
Article
en En
| MEDLINE
| ID: mdl-29355904
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Dermatosis del Cuero Cabelludo
/
Diterpenos
/
Dermatosis Facial
/
Queratosis Actínica
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País como asunto:
Asia
Idioma:
En
Año:
2018
Tipo del documento:
Article